Phytopharm sows seeds of success
Article Abstract:
Richard Dixey, Chief Exec of UK biotechnology firm Phytopharm, believes that the proteomics and genomics revolution is over-hyped, and that drug discovery should look at the natural world. Phytopharm bases its drugs on proven plant-based remedies.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Phytopharm
Article Abstract:
Phytopharm has drugs that could potentially perform well in the market, though the company also faces challenges such as clinical trials.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Phytopharm
Article Abstract:
Phytopharm has a number of potentially successful drugs, though there is no certainty that they will get through clinical trials.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Where is the new paradigm in health care costs? The cycle returns. Much remains in providing health care efficiencies
- Abstracts: Ethics in estate planning. The golden rule and financial service professionals. Pinocchio, the agent, and integrity
- Abstracts: Rowland Comms. Worldwide. Environics Comms. Access Comms
- Abstracts: Toplin & Assocs. Strategy Assocs. Schneider & Assocs
- Abstracts: Toplin & Assocs. Dennis Davidson Assocs